Clinicians must carefully evaluate baseline kidney function before initiating weight loss injections and monitor patients throughout treatment, particularly those with pre-existing kidney disease or multiple cardiovascular risk factors
These drugs mimic a hormone called glucagon-like peptide-1, which helps regulate blood sugar and appetite
Whether these next-generation compounds will offer even broader non-weight-loss benefits remains an active area of investigation
COMPOUNDED DRUGS When medication is compounded at a pharmacy into a single-dose syringe, many insurance carriers prefer the unlisted J-codes J3490 or J3590
In mice, obesity and the associated visceral adipose tissue inflammation result in insulin resistance, a process which appears to be mediated via increased synthesis and release of hepatic DPP-4, since eliminating hepatocyte Dpp4 expression suppresses inflammation and improves insulin sensitivity (82, 83)
While it can be caused by benign factors like dehydration, it may also indicate more serious health issues requiring medical evaluation
